Related Experiment Videos
MAP kinase pathways activated by stress: the p38 MAPK pathway.
T Obata1, G E Brown, M B Yaffe
1Department of Medicine, Beth Israel Deaconess Medical Center, Boston, MA, USA.
Critical Care Medicine
|May 12, 2000
Summary
p38 mitogen-activated protein kinase (p38 MAPK) is a stress-activated enzyme crucial for cellular responses. Inhibitors targeting p38 MAPK may offer therapeutic benefits for various diseases.
Area of Science:
- Biochemistry
- Molecular Biology
- Cellular Signaling
Background:
- p38 mitogen-activated protein kinase (p38 MAPK) is a key enzyme in the MAP kinase superfamily.
- It is activated by diverse extracellular stimuli, including stress and inflammatory signals.
- Activation occurs via phosphorylation of a TGY motif in the kinase activation loop.
Purpose of the Study:
- To elucidate the multifaceted roles of p38 MAPK in cellular processes.
- To investigate the involvement of p38 MAPK in various human diseases.
- To highlight the therapeutic potential of p38 MAPK inhibitors.
Main Methods:
- The abstract does not specify methods but implies the use of biochemical assays and potentially genetic or pharmacological approaches to study p38 MAPK.
- Focus on understanding the stress-activated protein kinase cascade.
- Utilizing specific inhibitors to probe p38 MAPK function.
Main Results:
- p38 MAPK plays significant roles in apoptosis, cytokine production, transcriptional regulation, and cytoskeletal reorganization.
- The kinase is implicated in the pathogenesis of sepsis, ischemic heart disease, arthritis, HIV infection, and Alzheimer's disease.
Conclusions:
- p38 MAPK is a critical mediator of cellular stress responses.
- Targeting p38 MAPK with inhibitors shows promise for treating inflammatory and degenerative diseases.
- Further research into p38 MAPK pathways could lead to novel therapeutic strategies.